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Myocardial stunning describes the phenomenon of re-
versible contractile dysfunction of viable myocardium after
restoration of normal or nearly normal epicardial coronary
flow following myocardial ischemia. In man, myocardial
stunning has been observed following cardiac surgery (glob-
al ischemia and reperfusion), in myocardial infarction after
timely reperfusion therapy (regional prolonged severe ische-
mia and reperfusion with stunned myocardium around areas
of necrosis), in unstable angina and coronary spasm (regional
transient ischemia without or with minimal necrosis), and in
exercise-induced angina (demand ischemia with almost nor-
mal blood flow). Recurrent episodes of stunning might result
in hibernating myocardium [1,2]. The designs of experiments
used to elucidate the cellular and molecular mechanisms
involved in myocardial stunning were as heterogeneous as
the clinical settings involved in this phenomenon.
Oxygen-free radicals and intracellular calcium overload
have been identified as two pathogenetic mechanisms in-
ducing intracellular damage that results in contractile dys-
function [1–3]. These pathogenetic processes adversely
affect several molecular targets that can potentially contrib-
ute to myocardial stunning (Table 1 and Refs. [1–3]), and
will result in a change of the proteomics of the myocyte.
Contractile function is the result of a complex and fine-
tuned interplay of the myofilament proteins. Disturbances of
each of the parts composing this intricate system may lead
to contractile dysfunction and contribute to myocardial
stunning [3,4]. Accordingly, changes in the thick filament,
mainly composed of myosin heavy chains and the associ-
ated light chains, and in the thin filament, composed of
polymeric actin, troponin (Tn), tropomyosin, and the struc-0008-6363/$ - see front matter D 2004 European Society of Cardiology. Publishe
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proteolytic TnI degradation as a possible molecular mech-
anism of stunning. Strong indirect evidence has revealed
that calcium-activated proteases such as calpain I, which
cleaves both TnI and TnT in vitro, are activated by the
intracellular calcium overload and result in specific troponin
I degradation by proteolysis [4,5]. The main degradation
product is a fragment, TnI 1–193, from the C-terminus. In
addition, calcium activates transglutaminases, which form
covalent complexes of the troponin degradation products.
The TnI degradation product and its interference with the
myofilaments were thought to exert the contractile dysfunc-
tion of myocardial stunning in the isolated perfused rat heart
[4,5]. Several observations suggested that the proteolytic
troponin I degradation product TnI 1–193 could replicate the
phenotype of stunning. First, incorporation of the troponin
complex from stunned myocardium into rabbit skeletal
muscle fibers resulted in a decreased calcium sensitivity
and force generation as compared to controls [6]. Second, in
a transgenic mouse model over-expressing the cleaved TnI
1–193, the phenotype of stunned myocardium, i.e. dimin-
ished calcium-activated tension but intact response to h-
adrenergic stimulation, was reproduced [7]. According to
this evidence, it was proposed that damage to the myofil-
ament proteins caused contractile dysfunction, and, like-
wise, the repair or restoration of normal proteins over time
was responsible for the transient nature of stunning. This
attractive explanation has been questioned based on recent
experiments. In biochemical assays, the degradation product
TnI 1–193 actually showed an increased calcium sensitivity
compared to normal TnI [8,9]. In isolated rat hearts sub-
jected to ischemia and reperfusion that resulted in myocar-
dial stunning, the degradation of TnI could be prevented by
keeping normal left ventricular filling pressures [10,11].
Furthermore, in stunned myocardium induced by regional
ischemia in the swine [12,13] and the dog [14], degradation
of TnI was absent. Therefore, TnI degradation was able tod by Elsevier B.V. All rights reserved.
Table 1
Possible mechanisms involved in myocardial stunning
. Triggers: oxygen-free radicals and calcium overload
. Abnormalities of proteins of the contractile apparatus (e.g. troponin I,
troponin T, myosin-regulatory light chain 2)
. Abnormalities of calcium-handling proteins (e.g. phospholamban, SR-
Ca2 +-ATPase)
. Impaired energy production and impaired energy use by myofibrils
. Damage to extracellular matrix
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primary mechanism of myocardial stunning.
In this issue of Cardiovascular Research, Colantonio et
al. [15] add further evidence to the notion that TnI degra-
dation may not be essential for myocardial stunning. In an in
vivo animal model of myocardial infarction, the authors
examined whether in viable, but stunned, peri-infarct tissue,
degradation of TnI or other troponins (TnT or TnC) con-
tributed to myocardial stunning. No degradation of TnI and
of TnC was detected. However, they found that TnT was
degraded. In a few animals, covalent complexes were
detected. Covalent complexes are purportedly composed
of TnI fragments bound to TnT, suggesting that minimal
TnI degradation had taken place in some animals; but
neither the extent of TnT degradation nor the presence or
absence of covalent complexes were associated with myo-
cardial stunning. The authors conclude that, similar to TnI
degradation, TnT degradation plays no integral role in the
pathogenesis of stunned myocardium.
An ancillary aim of the paper was to test whether
preconditioning affected troponin degradation. As in many
previous experiments [1,2], preconditioning did not affect
myocardial stunning during the 3-h recovery period. Nev-
ertheless, preconditioning did decrease the rate of TnT
degradation. The authors speculate that this could result in
better long-term functional recovery.
Where do these findings leave us? Can we discard TnI
degradation or abnormalities of the myofilaments as a cause
of myocardial stunning? As a primary cause of myocardial
stunning in large animals, we probably can. However,
troponin degradation and other changes in the myofilaments
occur during ischemia and reperfusion. These abnormalities
of the myofilaments induce contractile dysfunction. It has
been pointed out that such changes may contribute to global
LV dysfunction in other disease states [5,8]. Given the wide
variety of experimental and clinical situations accompanied
by myocardial stunning, it is also conceivable that abnor-
malities in the contractile proteins contribute to some forms
of stunning and not to others.
With respect to molecular mechanisms responsible for
myocardial stunning, it is generally assumed that reactive
oxygen species and calcium trigger stunning. Experimen-
tally scavenging free oxygen radicals and preventing calci-
um overload during reperfusion attenuate myocardial
stunning. Questions remain about the source of reactive
oxygen species in ischemia–reperfusion and how theycontribute to contractile dysfunction [3,16]. However, the
central role of reactive oxygen species as a signaling
mechanism for a large array of molecular networks and
metabolic pathways is recognized [16], and it is well
conceivable that they are important in protection mecha-
nisms such as preconditioning and in damaging the cell as in
myocardial stunning. The role of abnormalities of calcium
handling in myocardial stunning has recently been re-
examined [13,14]. Kim et al. [13] delineated nicely the
difference of calcium handling in stunned myocardium of
the swine and the rat. They found decreased calcium
transients and slowed relaxation in the swine, whereas in
rats the calcium transient was unchanged and relaxation was
accelerated despite contractile dysfunction. Although the
examined expression of calcium handling proteins was not
altered in the stunned myocardium, the phosphorylation of
phospholamban was reduced [13,14]. Therefore, abnormal-
ities in calcium handling may well play an important role in
myocardial stunning in large animals [3]. Further explora-
tion of the signaling pathways of reactive oxygen species
and calcium and, in addition, renewed examination of
abnormalities in calcium handling might advance our un-
derstanding of the mechanisms involved in myocardial
stunning.
What about some of the previously discarded causes of
myocardial stunning [17]? Impaired energy production by
mitochondria or impaired energy use by myofibrils as
causes of myocardial stunning have been discarded, since
decreased adenosine triphosphate (ATP) levels and the
extent of contractile dysfunction were dissociated. However,
it has been subsequently demonstrated that not ATP content
but rather ATP turn-over and, more importantly, the free
energy released from ATP hydrolysis determine the ener-
getics of the cell [18]. The normal function of enzymes
depends on the free energy available to them. SR-Ca2 +-
ATPase requires the highest free energy (52 kJ/mol) for
normal function and will be the first ion pump to be
impaired by inadequate energy production. Given the de-
pendence of calcium-handling proteins on normal energetics
[19] and the importance of calcium in myocardial stunning,
it is plausible that abnormalities of energy metabolism
contribute to myocardial stunning after all. Furthermore,
in a series of experiments Taegtmeyer et al. [20] have shown
that efficient myocardial contractile function is dependent
on a series of moiety-conserved cycles, of which the citric
acid cycle seems to be the most important. Ischemia and
reperfusion result in a transformation of efficient metabolic
cycles to less efficient linear pathways [20]. In addition,
during ischemia and reperfusion, residual oxidative phos-
phorylation is dominated by free fatty acid oxidation, and
glucose becomes uncoupled from oxidation; thus, mito-
chondrial ATP production is impaired [19]. Replenishment
of the citric acid cycle by anaplerotic reactions during
reperfusion has been shown to improve post-ischemic
contractile dysfunction [20]. In that regard, it is interesting
to note that pyruvate, which can directly enter the citric acid
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via anaplerotic reactions, attenuated myocardial stunning in
the swine [21]. Therefore, by indirect effects on ion homeo-
stasis or direct effects on contractile function, energetics
could influence myocardial stunning to some extent.
In summary, several complex molecular systems, i.e.
reactive oxygen species, calcium-handling proteins, meta-
bolic pathways including oxidative phosphorylation, and
proteins of the contractile apparatus, are directly or indi-
rectly involved in myocardial stunning. There are likely
additional, yet unknown mechanisms associated with myo-
cardial stunning. New methods such as proteomic and
genomic studies might help elucidate how these multiple
systems are linked and which ones are the most important
pieces of the puzzle.Acknowledgements
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